These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Mechanisms of alloimmunization in sickle cell disease. Hudson KE, Fasano RM, Karafin MS, Hendrickson JE, Francis RO. Curr Opin Hematol; 2019 Nov; 26(6):434-441. PubMed ID: 31483335 [Abstract] [Full Text] [Related]
8. Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease. Rankin A, Darbari D, Campbell A, Webb J, Mo YD, Jacquot C, Delaney M, Luban NLC, Nickel RS. Transfusion; 2021 Aug; 61(8):2255-2264. PubMed ID: 34002408 [Abstract] [Full Text] [Related]
10. Red blood cell alloimmunization in sickle cell disease patients in Uganda. Natukunda B, Schonewille H, Ndugwa C, Brand A. Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949 [Abstract] [Full Text] [Related]
11. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review. Fasano RM, Meyer EK, Branscomb J, White MS, Gibson RW, Eckman JR. Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266 [Abstract] [Full Text] [Related]
12. Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion. Chonat S, Arthur CM, Zerra PE, Maier CL, Jajosky RP, Yee MEM, Miller MJ, Josephson CD, Roback JD, Fasano R, Stowell SR. Transfus Clin Biol; 2019 May; 26(2):130-134. PubMed ID: 30979566 [Abstract] [Full Text] [Related]
13. [Delayed hemolytic transfusion reaction in sicle cell disease patients: a new challenge for the Hemovigilance network]. Rieux C, De Meyer E, Boudjedir K. Transfus Clin Biol; 2015 Mar; 22(1):37-41. PubMed ID: 25441454 [Abstract] [Full Text] [Related]
15. Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series. Nickel RS, Hendrickson JE, Fasano RM, Meyer EK, Winkler AM, Yee MM, Lane PA, Jones YA, Pashankar FD, New T, Josephson CD, Stowell SR. Transfusion; 2016 Jan; 56(1):107-14. PubMed ID: 26509333 [Abstract] [Full Text] [Related]
16. Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease. Fasano RM, Booth GS, Miles M, Du L, Koyama T, Meier ER, Luban NL. Br J Haematol; 2015 Jan; 168(2):291-300. PubMed ID: 25256676 [Abstract] [Full Text] [Related]
19. Red blood cell alloimmunization mitigation strategies. Hendrickson JE, Tormey CA, Shaz BH. Transfus Med Rev; 2014 Jul; 28(3):137-44. PubMed ID: 24928468 [Abstract] [Full Text] [Related]
20. HLA Class II regulation of immune response in sickle cell disease patients: Susceptibility to red blood cell alloimmunization (systematic review and meta-analysis). Wong K, Lai WK, Jackson DE. Vox Sang; 2022 Nov; 117(11):1251-1261. PubMed ID: 36102140 [Abstract] [Full Text] [Related] Page: [Next] [New Search]